Renewables push China’s fossil‑fuelled power into first annual drop in 10 years
BEIJING, Jan 19 (Reuters) – China’s mostly coal-based thermal power generation fell in 2025 for the first time…
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalledTzield pushed back after adverse event…
US FDA requests removal of suicide warnings from weight-loss drug labels
Jan 13 (Reuters) – The U.S. health regulator asked drugmakers on Tuesday to remove label warnings about a…
China urges industrial parks to use more on-site green power
BEIJING, Jan 9 (Reuters) – China is pushing industrial parks to use more of their green power on-site…
Demand for AI, tech experts pushes UK financial sector vacancies up 12%, recruiter says
LONDON, Jan 12 (Reuters) – Demand for workers in AI, regulation, data reporting and other specialist skills drove…
US FDA approves Vanda Pharmaceuticals’ motion sickness drug
Dec 30 (Reuters) – Vanda Pharmaceuticals (VNDA.O), opens new tab said on Tuesday its drug for the prevention…